In contrast, plasma glucagon levels only showed a trend of decrease in the whole gut gcg knockout mice and no change in distal gut gcg knockout mice compared with wild type mice, suggesting glucagon production is mainly produced from the pancreatic α-cell.
← all phrases
“showed a trend”
In the literature
The transcriptional levels of these tested genes through qRT-PCR analysis showed a trend similar to that of the RNA-Seq data ( Supplementary Figure S2 ), indicating the high reliability of the RNA-Seq data.
Most of the risky genes showed a trend of positive correlation with macrophage infiltration and negative correlation with B cells.
Moreover, the total citations showed a trend similar to that of annual publications.
Except for fluoroquinolones, the DOT per 1,000 PD for carbapenems, piperacillin-tazobactam, and cefepime showed a trend toward a significant increase (Supplementary Fig. 1 ).
The same results were observed for the CEA values that showed a trend of reduction although not statistically significant.
T cell subsets, NK cells and natural killer T cells (NKT) showed a trend for reduction, although not significant (CD3 + CD4 + T cells: 0.39 ± 0.05 vs. 1.67 ± 0.15 * 10 2 cells/μl; CD3 + CD8 + T cells: 0.16 ± 0.03 vs. 1.03 ± 0.12 * 10 2 cells/μl; NK cells: 0.15 ± 0.03 vs. 1.00 ± 0.25 * 10 2 cells/μl; NKT cells: 0.02 ± 0.01 vs. 0.11 ± 0.03 * 10 2 cells/μl; for all cell subsets p > 0.05).
As depicted in Figure 5 , the economic linkage of the GBA from 2010 to 2020 was rising fast, and the linkage of Guangzhou-Foshan occupying the core position showed a trend of extending from the central city to the peripheral cities.
Survival curve analyses showed that a significantly higher number of H-GSH rats reached higher breakpoints ( Figure 3—figure supplement 1h ) and this group also showed a trend toward nosepoking over a longer period of time ( Figure 3—figure supplement 1i ).
Patients with Non-painful Diabetic Neuropathy (NPDPN Q+SOC) showed a trend toward an improvement of the warm threshold, but it was not statistically significant.
Correlation of DTI metrics and cognitive output Low diffusivities showed a trend towards higher cognitive scores in many ROIs but in most cases, it did not reach statistical significance after correction of the p -value for multiple comparisons.
The RMSD of the compound relative to 3-C like protease maintained an increasing trend in the first 25 ns or so, and showed a trend of decreasing and then increasing to the RMSD value at 25 ns from 25 to 40 ns, and basically maintained equilibrium with less fluctuation in the last 10 ns.
Both EXTEM and INTEM CT showed a trend towards longer clotting time indicating reduced amounts of clotting factors.
Since in TASTPM we detected a significant sham effect and SNI ipsilateral thresholds showed a trend to be higher than WT, we performed an area under the curve (AUC) analysis.
Mice subsequently treated with Abatacept and IgG-(IL-2) 2 showed a trend towards retention of more functional beta cell mass as judged by glucose tolerance tests (Supplementary Fig. 8 ).
The third study failed to demonstrate antidepressant efficacy of pioglitazone over placebo and in fact showed a trend favoring placebo.
In the majority of cell lines, we observed an expected increase in ROS exposure in response to radiation, which showed a trend to be further increased by SG starvation (Fig. 1d and Supplementary Fig.
The Oncotype Dx score was higher expressed in young BC in the HER2 subtype, and the PCNA score showed a trend of higher expression in young TNBC (Fig. 2g–h ).
73 Interestingly, 7 R/R patients received the triplet ENA+AZA+Ven and showed a trend toward a better mOS than those treated with ENA+AZA. 73 Preliminary results of a phase Ib/II clinical trial (Enaven-AML trial) explored enasidenib in combination with VEN in a group of AML patients previously treated with at least two lines of treatment and mostly with relapsing or refractory disease. 74 A CR rate of 55% was observed, and all responders remained in remission during the study. 74 Since IDH mutations induced inhibition of the TET2 enzyme, it seemed interesting to explore the effect of VEN-based therapies in TET2 -mutated AMLs.
Age-standardized DALY rates showed a trend of fluctuation by ARIMA (2,0,2) model beyond 2019, estimated as 91.52 (95% UI: 87.11–95.94) by 2050.
Interestingly, patients treated with ADA showed a trend towards weight gain from induction to 24 months but not further.
The rs115025140 is unique to the African population and in a clinical cohort of African Americans taking statins for lipid control rs115025140 carriers showed a trend toward reduced statin‐mediated lipid reduction.
These modifications showed a trend towards the level of the control group, suggesting patterns of neural changes following TT.
1 Indeed, the PARAGON-HF study recently showed a trend towards better clinical outcome in chronic renal failure patients treated with sacubitril/valsartan than valsartan itself, especially in the lower end of the EF spectrum, in women, in patients recently hospitalized for heart failure and in those with high sensitivity troponin values at baseline.
The control groups showed relatively less outgrowth reaching the striatum, whereas slices exposed to the magnetic device showed a trend for denser outgrowth ( figure 7 b ).